Of all cells in the human body, erythrocytes express the highest level of the GLUT1 glucose transporter, with more than 200,000 molecules per cell (Mueckler et al., 1985) . We found that GLUT1 expression is significantly upregulated in late-stage erythroblasts, whereas glucose transport is decreased (Montel-Hagen et al., 2008a) . This increase in GLUT1 expression was associated with enhanced transport of L-dehydroascorbic acid (DHA), an oxidized intermediate of ascorbic acid (AA). Moreover, the efficient capture of DHA by erythrocyte GLUT1 and its immediate reduction to AA constitutes a recycling system that has evolved in those mammals incapable of synthesizing vitamin C. This system differs markedly from that observed in the adult erythrocytes of other species, which do not express GLUT1 and do not transport DHA. Thus, GLUT1 expression by erythrocytes is specifically associated with increased DHA transport, whereas erythrocyte glucose uptake can be achieved using other GLUT transporters.
Glucose Transport in Human Blood
Cell Progenitors Carruthers and Naftalin question whether our measurements of glucose uptake (2-deoxyglucose, 2DG) in human erythroid progenitors reflected decreased hexokinase activity rather than changes in actual transport. They base their argument on reference publications stating that hexokinase activity is high in erythroblasts and is downregulated during erythroid differentiation (Magnani et al., 1984; Shinohara et al., 1985) . However, this argument is spurious as we demonstrated that glucose transport is already decreased in human immature erythroblasts (Montel-Hagen et al., 2008a) , where the hexokinase activity is very high (Magnani et al., 1984) .
To further corroborate these data, we performed glucose uptake studies at early time points during erythroid differentiation induced by recombinant erythropoietin (rEPO), when most cells are proerythroblasts or basophilic erythroblasts (for example, see Giarratana et al., 2005; Figure 1A in Montel-Hagen et al., 2008a) . These immature erythroblasts have high hexokinase activity (Magnani et al., 1984; Shinohara et al., 1985) , but we still performed transport assays on ice in order to minimize variations in enzymatic activity. As demonstrated in kinetic analyses, glucose transport in early erythroblasts (day 3 of differentiation) was significantly decreased compared to that in CD34 + hematopoietic progenitor cells, at time points as early as 1 s (see day 0 versus day 3 in Figure  S1A of this Response, available online). We also addressed the relative contributions of glucose transport and hexokinase activity by assessing the uptake of 3-O-methylglucose (3-OMG) at an early time point of erythropoiesis (day 2 of differentiation). These uptake data (see Figure S1B here), using a nonmetabolizable sugar analog, remain concordant with our previous experiments, thereby addressing the concern raised by Carruthers and Naftalin. We can indeed assert that diminished glucose uptake during erythroid differentiation of CD34 + progenitor cells results from decreased glucose transport.
GLUT1-Mediated DHA Transport
We also demonstrated that GLUT1-mediated DHA uptake in human red blood cells is not inhibited by glucose. Carruthers and Naftalin state that these results are inconsistent with previous findings, but they miss the key point that erythrocytes differ from other cell types. In nonerythroid cells, glucose indeed inhibits GLUT1-mediated DHA uptake, as shown by several groups (for example, see Rumsey et al., 1997; Montel-Hagen et al., 2008a) . The sole publication that Carruthers and Naftalin cite to support their claim that glucose competitively inhibits DHA uptake in erythroid cells dates from 1975 and is quoted out of context. This elegant study, performed years before GLUT1 was identified, used supraphysiological glucose concentrations to compete away DHA (Mann and Newton, 1975) . This study has since been refuted by key publications demonstrating efficient and rapid DHA uptake by erythrocytes, even in the presence of a 50-fold molar excess of glucose (for example see Mendiratta et al., 1998) . Our results (Montel-Hagen et al., 2008a and Figure S2 here) are in complete agreement with these latter studies. Thus, Carruthers and Naftalin seem to have overlooked published literature documenting differences between erythrocytes and nucleated cells. Moreover, a recent publication has shown that glucose does not affect DHA uptake in infant dog erythrocytes expressing high levels of GLUT1 (Ogawa, 2009 ). Thus, in erythrocytes, physiological glucose concentrations do not competitively inhibit GLUT1-mediated transport of DHA.
Response Species Diversity in GLUT Expression and Function
We would like to point out that under physiological conditions, the major substrate for GLUT1, even in mature human erythrocytes, is most likely to be glucose because plasma glucose concentrations are ~5 mM, whereas the plasma level of DHA is less than 2 µM (reviewed in May, 1998) . Because it is present at a 3-log lower molarity than glucose, DHA transport into human erythrocytes by GLUT1 must be noncompetitive with glucose.
Stomatin and GLUT1 Function
Carruthers and Naftalin also question our finding of the role of stomatin in modulating GLUT1 activity in human erythrocytes. Notably, it was earlier studies that identified stomatin as a GLUT1-binding partner and showed that association of GLUT1 with stomatin decreases GLUT1-mediated glucose uptake (Zhang et al., 2001 ). We corroborated these results and demonstrated that DHA uptake increases under these conditions. Carruthers and Naftalin also question our transport experiments performed over 10 min in erythrocytes from patients with overhydrated hereditary stomatocytosis, who have low or no stomatin. However, Carruthers and Naftalin have overlooked our experiments on A431 cells harboring ectopic stomatin in which we obtained the same results at a time point where uptake was indeed in the linear range (30 s, Figure  S6 of Montel-Hagen et al., 2008a) , confirming the effects of stomatin on modulating GLUT1 function.
Erythropoiesis in Humans and Mice
We studied glucose transporters in erythrocytes of other species. Our experiments clearly showed that in those mammals capable of synthesizing vitamin C, erythrocyte expression of GLUT1 is rapidly lost during the neonatal period (Montel-Hagen et al., 2008a , 2008b . We further determined that in mice, the erythrocyte transporter expressed throughout life is GLUT4, even under conditions of anemiainduced erythropoiesis (Montel-Hagen et al., 2008a , 2008b . Thus, glucose transport in erythrocytes can be mediated by GLUT4, but the persistence of erythrocyte GLUT1 is characteristic of vitamin C-deficient species. In these latter species, erythrocyte GLUT1 promotes DHA uptake in the most abundant cell in the peripheral circulation, compensating, at least in part, for the inability to synthesize vitamin C.
Prior to our study, the widespread but incorrect assumption was that glucose transport in erythrocytes of all mammals was mediated by GLUT1 (for example, see Leitch and Carruthers, 2007; Naftalin and Rist, 1994) . One consequence of our work on the evolution of erythrocyte GLUT1 is our identification of a cardinal difference in glucose transporter expression between human and rodent erythrocytes, opening up new avenues of investigation into the differential roles of the GLUT1 and GLUT4 transporters in red cell physiology (Ogawa, 2009 
